North America

Healium Registers Clinical VR Biofeedback Platform as FDA Class II 510(k)-Exempt Device

The registration positions Healium Clinical for wider use in healthcare settings as a prescription-use immersive biofeedback, neurofeedback and relaxation training application. ...

RADIN Health and AZmed Expand AI Radiology Workflow Capabilities with FDA-Cleared AZtrauma Module

The expanded clearance broadens AZtrauma’s scope beyond fracture detection to include joint effusions and dislocations across adult and paediatric X-ray imaging. ...

Intuitive Announces Innovations to Advance Quintuple Aim

Latest innovations include enhanced telecollaboration capabilities, extended uses for Force Feedback technology, and advancements in product and instrument reliability and security...

IQity and Sightpath Medical Partner to Deliver Advanced Ophthalmic Technology to Surgeons

The agreement unites IQity's breakthrough technologies with Sightpath's nationwide service infrastructure...

Beckman Coulter Life Sciences Launches Next-Gen Echo 650 Plus Acoustic Liquid Handlers

New electronics architecture further enhances system performance, improving real-time computational capability, manufacturability and overall reliability...

Stryker Acquires AVS in $835 Million Deal to Expand Vascular Technology Portfolio

Three companies with strong roots in the state are revolutionising the treatment of cardiovascular disease through hydraulic lithotripsy technology...

HITLAB Validates MedsEngine’s Value in Treating Chronic Diseases

The evaluation, completed in March 2026, encompassed a full walkthrough of all four disease modules, clinical workflow integration assessment, usability analysis using the Nielsen heuristic framework...

Galvanize Therapeutics Secures FDA Clearance for Aliya EX Generator

The clearance expands Galvanize’s pulsed electric field portfolio for soft tissue ablation, supporting broader lesion treatment and limited US commercial release. ...

PorTal Access Completes FDA Submission for Flexi-Port Ahead of Planned Commercial Launch

The submission moves PorTal Access closer to a planned mid-summer launch, positioning Flexi-Port as a differentiated vascular access solution for oncology and long-term infusion therapy. ...

Nabsys Expands OhmX Platform Installations to Advance Hematologic Malignancy Research

RAMP UP programme with Hitachi High-Tech America supports electronic genome mapping studies in AML and MDS ...